Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

S&P 500 4-Q Estimate Compares Get Easier From Mid-October '15

Published 10/18/2015, 12:04 AM
Updated 07/09/2023, 06:31 AM

Regular readers know that Thomson Reuters' “forward 4-quarter estimate” for the S&P 500 is something that has been tracked on this site since my blog began in 2012.

The forward 4-quarter estimate as of October 17, 2014 was $129.34 and it has grown $10.40 or 9.5% since mid-October, 2013.

It has been uncomfortable to watch the negative y/y growth of the forward estimate, which started in May ’15, but the Energy and Basic Materials sectors drag on the forward estimate also had to be considered when examining the data.

Here is the point of this post: from this week forward, the year-over-year growth of the forward estimate starts to lap easier “forward growth rate” comparisons:

Here is the data:

  • 6/13/14: $122.96, y/y growth = 8.51%
  • 7/18/14: $127.07, y/y growth = 8.57%
  • 8/15/14: $126.58: y/y growth = 9.40%
  • 9/19/14: $125.79 y/y growth = 8.56%
  • 10/17/14: $129.34, y/y growth = 9.49%
  • 11/17/14: $126.64, y/y growth = 7.54%
  • 12/19/14: $123.48 y/y growth = 5.71%
  • 1/16/15: $124.91, y/y growth = 4.77%
  • 2/13/15: $120.83, y/y growth = 1.35%
  • 3/13/15: $119.78, y/y growth = 0.82%
  • 4/17/15: $123.49, y/y growth = 0.62%
  • 5/15/15: $122.23, y/y growth = -0.51%

The forward 4-quarter estimate for the S&P 500 has been negative ever since mid-May ’15. No question the decline in crude oil was starting to be perceived as something other than temporary, and the US dollar was starting a 22% ramp versus the euro.

While readers might consider this ultimate data navel-gazing, I think the “forward 4-quarter estimate” has some analytical importance. It is a weekly metric that – for better or worse – gives readers the best look at what the 1-year forward S&P 500 EPS earnings looks like, and it’s updated every week.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Near the depths of the selloff in late August ’15, this post was written about the Energy sector and the Internationals beginning to lap easier comparisons in Q4 ’15.

Bespoke had an interesting line in their weekly Bespoke Report published Friday night, 10/16/15:

“Since the rally began on September 29th, the bounce higher has been led by stocks that prior to this point in the year had been struggling significantly….Over the last couple of weeks, though, we’ve seen the international stocks outperform domestics significantly.”

Per Bespoke, S&P 500 stocks that generate more than 50% of their revenue outside the US, are up an average 9.38% since 9/29. Conversely, stocks that generate all their revenue from within the US are up an average 5.63%.

Analysis / conclusion: The sector rotation happening within the S&P 500 could be more involved than many think. For me, Apple (O:AAPL) and biotech still hold the key to the market leadership. I’m more confident that Apple can re-take its 200-day moving average, than biotech, so if biotech reports solid EPS and revenue growth and the sector continues to languish, the bid in Emerging Markets, and Non-US large-cap stocks within the S&P 500 might have some traction. (Long AAPL, missed the biotech bull market.)

The expectation too is that sometime in the next 6-12 weeks, the S&P 500’s “forward 4-quarter” estimate starts to turn positive again.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.